Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women

Iversen, Ole‐Erik; J. Miranda, María; Ulied, Àngels; Soerdal, Terje; Lazarus, Erica; Chokephaibulkit, Kulkanya; L. Block, Stan; Skřivánek, A; Ghani Nur Azurah, Abdul; Moy Fong, Siew; Dvořák, Vladimír; Kim, Kyung‐Hyo; M. Cestero, Ramón; Berkovitch, Matitiahu; Ceyhan, Mehmet; C. Ellison, Misoo; Ritter, Michael; Yuan, Shuai; J. DiNubile, Mark; J. Saah, Alfred; Luxembourg, Alain

doi:10.1001/jama.2016.17615

Public

Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women

Published in JAMA • Nov 28, 2016

Authors:

Ole‐Erik Iversen

María J. Miranda

Àngels Ulied

Abstract

Importance: Human papillomavirus (HPV) infections cause anogenital cancers and warts. The 9-valent HPV vaccine provides protection against 7 high-risk types of HPV responsible for 90% of cervical cancers and 2 other HPV types accounting for 90% of genital warts. Objective: To determine whether HPV t...

Subject

Medicine

Regimen

Genital warts

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!